Search

everythinglearnresearchcommunity

for

Search:↓

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

The document concludes that PCOS in adolescents is complex and requires comprehensive care to manage its symptoms and associated health risks.

The exact cause of growth hormone-responsive alopecia in dogs is unclear.

Paeoniflorin protects brain cells by involving a specific protein and neurosteroids.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

Editing the FGF5 gene in sheep increases fine wool growth.

Nanog gene boosts stem cells, helps hair growth, and may treat hair loss.

Allopregnanolone can reduce gut inflammation and normalize neurotransmitter levels after finasteride withdrawal.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

The foreword introduces a medical issue discussing male hormonal health, treatments, and the effects of conditions like obesity and aging.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

New treatment using engineered nanovesicles in hydrogel improves hair growth by repairing hair follicle cells in a mouse model of hair loss.